155 related articles for article (PubMed ID: 33625649)
21. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
[TBL] [Abstract][Full Text] [Related]
22. Review of early endoscopic findings in patients with local recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
Yamamoto Y; Kadota T; Yoda Y; Hori K; Hatogai K; Kojima T; Fujii S; Akimoto T; Yano T
Esophagus; 2020 Oct; 17(4):433-439. PubMed ID: 32232702
[TBL] [Abstract][Full Text] [Related]
23. Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patients.
Yamashita H; Jingu K; Niibe Y; Katsui K; Matsumoto T; Nishina T; Terahara A
Radiat Oncol; 2017 Feb; 12(1):38. PubMed ID: 28219406
[TBL] [Abstract][Full Text] [Related]
24. Eight cases of salvage pulmonary resection for residual disease or isolated local recurrence detected after definitive chemoradiotherapy for N2 Stage-IIIA lung cancer.
Sawada S; Suehisa H; Ueno T; Yamashita M
Asian J Surg; 2017 Apr; 40(2):95-99. PubMed ID: 26362070
[TBL] [Abstract][Full Text] [Related]
25. Patterns of Relapse after Definitive Chemoradiotherapy in Stage II/III (Non-T4) Esophageal Squamous Cell Carcinoma.
Sudo K; Kato K; Kuwabara H; Sasaki Y; Takahashi N; Shoji H; Iwasa S; Honma Y; Okita NT; Takashima A; Hamaguchi T; Yamada Y; Ito Y; Itami J; Fukuda T; Tobinai K; Boku N
Oncology; 2018; 94(1):47-54. PubMed ID: 29080886
[TBL] [Abstract][Full Text] [Related]
26. Prognostic analysis of salvage esophagectomy after definitive chemoradiotherapy for esophageal squamous cell carcinoma: the importance of lymphadenectomy.
Wang S; Tachimori Y; Hokamura N; Igaki H; Nakazato H; Kishino T
J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1805-11. PubMed ID: 24521950
[TBL] [Abstract][Full Text] [Related]
27. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
Chen J; Yin W; Yao H; Gu W
Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
[TBL] [Abstract][Full Text] [Related]
28. Long-term results of concurrent chemoradiotherapy with daily-low-dose continuous infusion of 5-fluorouracil and cisplatin (LDFP) for Stage I-II esophageal carcinoma.
Kumabe A; Fukada J; Kota R; Koike N; Shiraishi Y; Seki S; Yoshida K; Kitagawa Y; Shigematsu N
Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29228166
[TBL] [Abstract][Full Text] [Related]
29. Salvage esophagectomy for locoregional failure after chemoradiotherapy in patients with advanced esophageal cancer.
Yoo C; Park JH; Yoon DH; Park SI; Kim HR; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Kim YH; Kim SB
Ann Thorac Surg; 2012 Dec; 94(6):1862-8. PubMed ID: 22959577
[TBL] [Abstract][Full Text] [Related]
30. Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.
de Vos-Geelen J; Geurts SME; Nieuwenhuijzen GAP; Voncken FEM; Bogers JA; Braam PM; Muijs CT; de Jong MA; Kasperts N; Rozema T; Blom GJ; Bouwense SAW; Valkenburg-van Iersel LBJ; Jeene PM; Hoebers FJP; Tjan-Heijnen VCG
Eur J Surg Oncol; 2021 Aug; 47(8):2016-2022. PubMed ID: 33583629
[TBL] [Abstract][Full Text] [Related]
31. Salvage endoscopic submucosal dissection in patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
Takeuchi M; Kobayashi M; Hashimoto S; Mizuno K; Kawaguchi G; Sasamoto R; Aoyama H; Aoyagi Y
Scand J Gastroenterol; 2013 Sep; 48(9):1095-101. PubMed ID: 23906093
[TBL] [Abstract][Full Text] [Related]
32. [Salvage surgery in esophageal cancer : Feasibility in patients after definitive radiochemotherapy (> 50 Gy)].
Schmidt T; Sisic L; Sterzing F; Haag GM; Kunzmann R; Grenacher L; Weichert W; Jäger D; Büchler MW; Ott K
Chirurg; 2015 Oct; 86(10):955-62. PubMed ID: 25715974
[TBL] [Abstract][Full Text] [Related]
33. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Definitive Chemoradiotherapy Versus Radical Esophagectomy in Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma.
Haneda R; Booka E; Ishii K; Kikuchi H; Hiramatsu Y; Kamiya K; Ogawa H; Yasui H; Takeuchi H; Tsubosa Y
World J Surg; 2021 Jun; 45(6):1835-1844. PubMed ID: 33620541
[TBL] [Abstract][Full Text] [Related]
35. Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern.
Versteijne E; van Laarhoven HW; van Hooft JE; van Os RM; Geijsen ED; van Berge Henegouwen MI; Hulshof MC
Dis Esophagus; 2015 Jul; 28(5):453-9. PubMed ID: 24725186
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.
Sugawara K; Yagi K; Okumura Y; Nishida M; Aikou S; Yamashita H; Yamashita H; Seto Y
Int J Clin Oncol; 2020 Apr; 25(4):552-560. PubMed ID: 31828451
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.
Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J
Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349
[TBL] [Abstract][Full Text] [Related]
38. A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904).
Sasaki K; Nomura M; Kato K; Sakanaka K; Ito Y; Kadota T; Machida R; Kataoka T; Minashi K; Tsubosa Y; Kajiwara T; Fukuda H; Takeuchi H; Mizowaki T; Nishimura Y; Kitagawa Y
Jpn J Clin Oncol; 2024 Jan; 54(1):103-107. PubMed ID: 37801434
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of salvage endoscopic submucosal dissection for local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
Kimura H; Yoshida M; Yabuuchi Y; Kakushima N; Yamamoto Y; Kawata N; Takizawa K; Kishida Y; Imai K; Ito S; Hotta K; Ishiwatari H; Matsubayashi H; Ono H
Jpn J Clin Oncol; 2021 Jul; 51(7):1036-1043. PubMed ID: 33758950
[TBL] [Abstract][Full Text] [Related]
40. Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.
Kumagai K; Mariosa D; Tsai JA; Nilsson M; Ye W; Lundell L; Rouvelas I
Dis Esophagus; 2016 Oct; 29(7):734-739. PubMed ID: 26316181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
